233 related articles for article (PubMed ID: 12107221)
1. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.
Losa M; Mortini P; Barzaghi R; Gioia L; Giovanelli M
J Clin Endocrinol Metab; 2002 Jul; 87(7):3180-6. PubMed ID: 12107221
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
3. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
4. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
5. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
6. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
8. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
[TBL] [Abstract][Full Text] [Related]
9. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
Sabakhtarashvili MA; Veĭnberg EG; Kurashvili RB; Kanchaveli ZSh
Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors.
Charpentier G; de Plunkett T; Jedynak P; Peillon F; Le Gentil P; Racadot J; Visot A; Derome P
Horm Res; 1985; 22(3):222-7. PubMed ID: 4054842
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-secreting adenomas: surgical results and long-term follow-up.
Maira G; Anile C; De Marinis L; Barbarino A
Neurosurgery; 1989 May; 24(5):736-43. PubMed ID: 2716983
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
13. Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas.
Schlechte J; Vangilder J; Sherman B
J Clin Endocrinol Metab; 1981 Apr; 52(4):785-9. PubMed ID: 7193686
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.
Serri O; Rasio E; Beauregard H; Hardy J; Somma M
N Engl J Med; 1983 Aug; 309(5):280-3. PubMed ID: 6866052
[TBL] [Abstract][Full Text] [Related]
15. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.
Arafah BM; Prunty D; Ybarra J; Hlavin ML; Selman WR
J Clin Endocrinol Metab; 2000 May; 85(5):1789-93. PubMed ID: 10843153
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
Arafah BM; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
[TBL] [Abstract][Full Text] [Related]
18. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
19. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
20. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
